10/01/2024 - Press release
Functional alterations in the brains of individuals with this condition coincide with the distribution of these neurons in the same brain. These neurons are responsible for filtering external information reaching the brain. Their functioning is altered in individuals with schizophrenia, which explains the majority of their symptoms. This discovery is the first time that this alteration can be identified as a possible origin of schizophrenic symptoms, and it opens the door to seeking new targeted treatments with fewer patient side effects.
28/12/2023 - Press release
An observational study conducted by researchers from Pompeu Fabra University and Hospital del Mar determines that the intradermal administration of the JYNNEOS vaccine against smallpox induces an efficient immune response that should protect people living with HIV from contracting the monkeypox virus.
Stanford University has released a new edition of its list, which considers the most cited scientists in various disciplines, divided into 22 fields of knowledge. This time, the Hospital del Mar and the Hospital del Mar Research Institute have achieved a record number, with 33 professionals in the ranking.
People with HIV have altered levels of a specific RNA molecule related to both aging and inflammation. This molecule remains altered even with antiretroviral treatment, indicating that their immune system remains affected despite receiving antiretroviral treatment and controlling the infection. The authors of the study, published in the Journal of Microbiology, Immunology, and Infection, suggest that the origin of this alteration is chronic inflammation caused by the infection, regardless of the treatment received by patients. Having this marker can be helpful in monitoring the evolution of patients and the effectiveness of the drugs they take to restore the normal functioning of their immune system.
24/11/2023 - General information
33 new research projects received funding of up to 500,000 euros or up to one million euros in the sixth edition of the CaixaResearch Health Research call, promoted by the "la Caixa" Foundation. In total, 25.3 million euros in grants. The call supports basic, clinical, or translational research projects with scientific excellence and social impact in cardiovascular diseases, infections, oncology, and neurosciences. It also supports projects developing enabling technologies in these areas. Among the selected projects is one led by Dr. Toni Celià-Terrassa to advance the understanding of metastasis and its coevolution with the immune system. There are also two other projects with the participation of researchers from the Hospital del Mar, Dr. Víctor Pérez, and Dr. Arnau Busquets.
Researchers from the Hospital del Mar Research Institute have published a new article in Microbiology Spectrum proposing a novel approach to treating pneumonia caused by antibiotic-resistant Pseudomonas aeruginosa bacteria. The study suggests that increasing the dose of the antibiotic colistin may not only be ineffective, but could also increase patient mortality. For this reason, the researchers advocate for using nebulized administration of the treatment instead of intravenous administration. This approach achieves higher concentrations in the lungs, where the infection is located, without causing toxic colistin concentrations in the blood. The World Health Organization considers antibiotic resistance among the top 10 global public health threats.
16/11/2023 - Institutional news
The Universidad Francisco de Victoria (UFV), in association with the science and technology company MERCK, presents awards to researchers who have made significant clinical and scientific contributions in the field of cancer immunology research.
15/11/2023 - Institutional news
Evidence shows an annual loss of 34.6 million life-years globally due to suicide. In response to this, globally renowned institutions specialized in mental health and suicide research, in collaboration with experts in bioinformatics, have launched PERMANENS, a pioneering European research initiative. The PERMANENS research project is dedicated to create a medical software prototype that supports clinicians in delivering personalized assessments and care to patients arriving at the emergency department with an elevated risk of self-harm or suicide. This precision medicine software will harness the power of artificial intelligence to provide more accurate risk assessments and access to evidence-based information, enabling the identification of effective treatment options tailored to each patient's unique needs and risk profile.
10/11/2023 - Institutional news
The 2023 edition of the Scientific Retreat of the Hospital del Mar Research Institute was special. This annual meeting to review the highlights of the year at the institution also served to celebrate its 75th anniversary, making it the oldest active public research center in Spain. A benchmark facility in the field of biomedical research that looks to the future. The event was opened by Dr. Olga Pané, manager of the Hospital del Mar, who addressed the researchers, telling them to "make research a beacon of hope for patients and professionals, and a feat of society, which is materialized in our centers". In turn, the director of the Hospital del Mar Research Institute, Dr. Joaquín Arribas, wanted to emphasize that in the last twelve months, "our researchers, from group leaders to trainees, have managed to improve both the impact of publications and the attraction of competitive resources, as well as the translation to society".
Més informació "Scientific Retreat 2023, 75 years doing research"
09/11/2023 - Institutional news
The Hospital del Mar Research Institute will receive 1.5 million euros in funding from the 2022 La Marató de TV3 and Catalunya Ràdio. These funds will be distributed among four projects led by researchers at the institute in the field of cardiovascular health. Dr. Montse Fitó, coordinator of the Cardiovascular Risk and Nutrition Research Group, leads a project that will analyze the role of microRNA molecules in high-density lipoproteins (HDL) in the incidence of coronary heart disease, analyzing possible personalized treatment strategies for atherosclerosis. The Hospital de la Santa Creu i Sant Pau Research Institute, the Catalan Institute of Nanoscience and Nanotechnology, and the University of Valencia will participate. They will receive funding of almost 400,000 euros.
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
